Clinical Trial Update: 1064-nm Q-switched Nd:YAG Laser and Intradermal Tranexamic Acid for Melasma [NA]

View source ↗

Summary

A trial update on using a 1064-nm Q-switched Nd:YAG laser in combination with intradermal tranexamic acid for melasma; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• 1064-nm Q-switched Nd:YAG laser
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Melasma | NA | Status: UNKNOWN